婴儿期接种疫苗青少年加强后对乙肝表面抗原变异株的免疫应答
研究纳入142名15-21岁、婴儿期完成乙肝疫苗接种但抗-HBs阴性的青少年,评估加强针前后对HBsAg及T细胞表位变异株的细胞免疫和抗体亲和力。单剂加强后8.6%仍抗-HBs阴性,<17岁者抗-HBs滴度更高;细胞免疫对部分变异株改善,但对sG145R的抗体亲和力及部分表位IFN-γ应答仍受损。
要点
- 约10%抗-HBs消失的青少年也失去免疫记忆,单剂加强后8.6%仍阴性。
- 加强前HBsAg特异性细胞增殖存在于90.6%受试者,加强后T细胞表位应答增强。
- 加强后对sG145R抗体亲和力及部分表位IFN-γ应答仍低于野生型。
核心结论
- 在婴儿期接种后抗-HBs消失的青少年中,约10%也失去免疫记忆,加强针可改善对部分T细胞表位变异株的细胞免疫,但对sG145R的抗体亲和力及某些表位的IFN-γ应答仍受损。
研究设计与样本
- 招募142名15至21岁、婴儿期完成乙肝疫苗全程接种但抗-HBs阴性的青少年,评估加强针前后对HBsAg及T细胞表位变异株的细胞免疫,加强后评估抗体亲和力。
主要发现
- 单剂加强后140名中12名(8.6%)仍抗-HBs阴性。
- 抗-HBs滴度在<17岁者更高(几何均值337.9 ± 10.9 vs. 157.4 ± 16.6 mIU/mL,p=0.012)。
- 加强前HBsAg特异性细胞增殖存在于58/64(90.6%)受试者。
- T细胞表位增殖应答率加强前后分别为37.8%和72.6%(p<0.001),刺激指数从1.25 ± 1.70升至2.53 ± 2.32(p<0.001)。
- HBsAg特异性IL-5和IFN-γ分泌T细胞增强(分别从45 ± 10和50 ± 4升至420 ± 328和355 ± 424 spot-forming cells/10^6 cells,p<0.001)。
关键数值与推荐
- 加强后对含R24K的表位16-33的IFN-γ分泌T细胞及对sG145R的抗体亲和力仍显著低于野生型。
临床怎么用
- 对婴儿期接种后抗-HBs消失的青少年,加强针可增强对部分变异株的细胞免疫,但需关注对sG145R等变异株的免疫应答仍不充分。
局限性
- 样本量有限,未报告长期随访及临床保护力数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to investigate immunity against hepatitis B surface antigen (HBsAg) mutants before and after boosters in adolescents who had lost antibodies against HBsAg (anti-HBs) despite neonatal vaccination. METHODS: We recruited 142 participants from 15 to 21 years old who had received complete vaccination in infancy but became anti-HBs-negative. Cellular immunity to HBsAg and T-cell epitope variants was assessed before and after boosters. Antibody affinity to variants was assessed after boosters. RESULTS: After one dose of booster, 12 out of 140 (8.6%) participants remained anti-HBs-negative. Anti-HBs titres were higher in those participants <17 (geometric mean, 337.9 ± 10.9 vs. 157.4 ± 16.6 mIU/mL, p = 0.012). Before the booster, HBsAg-specific cell proliferation was present in 58 out of 64 (90.6%) participants. The proliferation response rates to T-cell epitopes were 37.8% and 72.6% (p < 0.001) before and after the booster, respectively. The stimulation index improved from 1.25 ± 1.70 to 2.53 ± 2.32 (p < 0.001) for various T-cell epitopes. HBsAg-specific interleukin (IL)-5- and interferon (IFN)-γ-secreting T-cells were enhanced (45 ± 10 and 50 ± 4 to 420 ± 328 and 355 ± 424 spot-forming cells/106 cells, respectively, p < 0.001). IFN-γ-secreting T cells to epitope 16-33 containing R24K and the antibody affinity to sG145R were still significantly lower than to the wild type. CONCLUSIONS: In immunized adolescents who lost anti-HBs, around 10% also lost immune memory. Cellular immunity to some T-cell epitope variants improved after the booster. Antibody affinity to sG145R and the IFN-γ-secreting cell response to some epitope 16-33 variants were still impaired even after booster administration.
引用
- Lai MW, Liang KH, Yeh CT, et al. Diverse immune responses to HBV surface epitope variants after vaccine booster in adolescents immunized in infancy. Clin Microbiol Infect. 2019. PMID: 30771531. doi:10.1016/j.cmi.2019.02.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。